OR WAIT null SECS
April 30, 2020
A comprehensive turnkey system based on LabVantage’s laboratory information management system platform allows laboratories to implement COVID-19 biobanking, testing, and research.
The company has expanded capabilities for aggregate analytics to include dynamic light scattering.
April 16, 2020
The lab is expected to open in April 2020 and will increase the company’s capacity for diagnostic testing of rare genetic diseases along with its COVID-19 capabilities.
March 27, 2020
The strategic alliance provides an integrated product offering around drug discovery and development.
The company has developed mathematical algorithms that generate simple cell-count data from a few days of culture.
The new NAB Nanosep device provides increased binding capacity.
The company has launched new high volume eight- and 12-channel pipettes, offering a capacity of 1250 µL per channel.
The transgenic mouse R&D platform will support the discovery of fully-human monoclonal antibodies.
March 06, 2020
The acquisition will expand Nexelis’ immunology testing expertise.
February 28, 2020
Eurofins DiscoverX partners with VelaLabs to enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions.